Alternatives to AbbVie

Elevating uterine health through innovative biomaterial therapies.

A global pure-play dermatology company focused on injectable aesthetics, dermatological skincare, and therapeutic medicine.

Biopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.

Global biopharmaceutical company focused on oncology, rare diseases, and neuroscience.

A global, research-driven biopharmaceutical group focused on reproductive medicine, maternal health, and other specialized therapeutic areas.

Biopharmaceutical company focused on developing orally administered therapeutics for inflammatory disorders and cancer.

A biologic medicine developed by Sanofi and Regeneron Pharmaceuticals for treating various inflammatory conditions.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Biotechnology company developing and commercializing cell therapies for cancer treatment.

Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.

Developing novel therapeutics to restore gut lymphatic function.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Enzyme-based technology to break down alcohol in the stomach.

Biopharmaceutical company developing and commercializing CNS disease treatments.